The long standing Hematology T32 Training Grant at the University of North Carolina at Chapel Hill (UNC-CH) remains committed to training both MD physician-scientists and PhD scientists for careers in academic hematology and hematology research. This program will continue to train adult and pediatric hematology fellows and PhD post- doctoral candidates in areas of traditional institutional research strengths encompassing benign hematology. Both basic bench and clinical research tracks are available, with carefully selected didactic coursework to complement the training experience. In this competitive renewal application, scientific and educational interactions between MD and PhD trainees in the form of conferences, journal clubs, and symposia have been emphasized. Following 2 years of training on the T32 grant, trainees will be encouraged to apply for individual or institutional K series awards, and/or other sources of independent funding.

Public Health Relevance

For over 35 years, the training program in academic hematology at the University of North Carolina at Chapel Hill (UNC-CH) has benefitted from support by the Ruth L. Kirschstein National Research Service Award. This program, which encompasses disorders of the blood, vasculature or immune system, has been extraordinarily successful in its mission to train clinical and bench researchers in hematology. The cornerstones of training include a mentored research project, focused seminars and conferences, training in the responsible conduct of research, and didactic coursework in clinical research, laboratory methodology, grantsmanship, and the academic community. Both MD and PhD postdoctoral candidates are recruited from intramural and extramural sources, and their frequent interaction during the 2-year period of support engenders a mutual respect and understanding of the ultimate goals of biomedical research in hematologic disorders.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Mondoro, Traci
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of North Carolina Chapel Hill
Internal Medicine/Medicine
Schools of Medicine
Chapel Hill
United States
Zip Code
Sparkenbaugh, Erica M; Chantrathammachart, Pichika; Mickelson, Jacqueline et al. (2014) Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease. Blood 123:1747-56
LeVine, Dana N; Birkenheuer, Adam J; Brooks, Marjory B et al. (2014) A novel canine model of immune thrombocytopenia: has immune thrombocytopenia (ITP) gone to the dogs? Br J Haematol 167:110-20
Xu, Yongmei; Cai, Chao; Chandarajoti, Kasemsiri et al. (2014) Homogeneous low-molecular-weight heparins with reversible anticoagulant activity. Nat Chem Biol 10:248-50
Whelihan, Matthew F; Kiankhooy, Armin; Brummel-Ziedins, Kathleen E (2014) Thrombin generation and fibrin clot formation under hypothermic conditions: an in vitro evaluation of tissue factor initiated whole blood coagulation. J Crit Care 29:24-30
Willemze, Rose; Bradford, Robert L; Mooberry, Micah J et al. (2014) Plasma microparticle tissue factor activity in patients with antiphospholipid antibodies with and without clinical complications. Thromb Res 133:187-9
Whelihan, Matthew F; Lim, Ming Y; Key, Nigel S (2014) Red blood cells and thrombin generation in sickle cell disease. Thromb Res 133 Suppl 1:S52-3
Chandarajoti, Kasemsiri; Xu, Yongmei; Sparkenbaugh, Erica et al. (2014) De novo synthesis of a narrow size distribution low-molecular-weight heparin. Glycobiology 24:476-86
Lu, Rommel P; Ni, Ai; Lin, Feng-Chang et al. (2013) Major burn injury is not associated with acute traumatic coagulopathy. J Trauma Acute Care Surg 74:1474-9
Buckner, Tyler W; Key, Nigel S (2012) Venous thrombosis in blacks. Circulation 125:837-9
Rein, Chantelle M; Desai, Umesh R; Church, Frank C (2011) Serpin-glycosaminoglycan interactions. Methods Enzymol 501:105-37

Showing the most recent 10 out of 27 publications